Company Update: SK pharmteco to Expand Capabilities with Acquisition of Controlling Interest in CBM |
Learn More
Search for:
About us
Leadership team
Direction and location
Code of Conduct and Ethics
Our new 5,000 m2 biomanufacturing site
Services
Bioprocess development (USP & DSP)
cGMP manufacturing of clinical & commercial batches
Analytical Development, Qualification & Validation – QC & QA
Fill & Finish
Regulatory Support
Our platforms
LentiSure™: Lentivirus Manufacturing Platform
AAVelocity™: AAV Manufacturing Platform
Innovation
News, blog & events
News
Blog
Events
Careers
Contact us
Search for:
News
All
News
Blog
Events
Yposkesi welcomes Brian Mullan, PhD, as director of innovation, analytical and process development
8 December 2020
Read more
Yposkesi welcomes Patrick Lansky as VP of US sales & marketing
2 March 2020
Read more
Yposkesi’s clinical batches of G1XCGD lentiviral vector used in rare immune system disease study
30 January 2020
Read more
Yposkesi selected to produce clinical and large-scale commercial material of micro-dystrophin for Genethon and Sarepta Therapeutics program
24 January 2020
Read more
Yposkesi sélectionné pour la Grande Exposition du Fabriqué en France à l’Elysée les 18 et 19 janvier 2020
24 January 2020
Read more
Yposkesi commited to support Telethon 2019
6 December 2019
Read more
Yposkesi’s viral vectors used in gene therapy-based clinical trial published in Nature Medicine.
9 September 2019
Read more
Yposkesi and Axovant sign strategic gene therapy development and manufacturing partnership.
20 June 2019
Read more
Servier appoints Yposkesi for lentiviral vector GMP-manufacturing in CAR-T cell development technology.
5 June 2019
Read more
Yposkesi names Morad El Gueddari new director of viral vector manufacturing.
23 April 2019
Read more
Load more News
Would you like to know more ?
Contact us